| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Receivable per license termination and transfer agreement-Annji | - | 800 | ||
| Cash and cash equivalents | 3,709 | 3,326 | ||
| Prepaid expenses and other current assets | 16 | 35 | ||
| Total assets | 3,725 | 4,161 | ||
| Accounts payable and accrued expenses-Nonrelated Party | 879 | 952 | ||
| Accounts payable and accrued expenses-Related Party | 541 | 377 | ||
| Warrant liability | 2 | 0 | ||
| Total current liabilities | 1,422 | 1,329 | ||
| Preferred stock | - | 0 | ||
| Total liabilities | 1,422 | 1,329 | ||
| Common shares, 3,183,558 and 2,108,670 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 0 | 0 | ||
| Additional paid-in capital | 108,337 | 108,155 | ||
| Accumulated deficit | -104,780 | -104,097 | ||
| Total stockholders equity attributed to the company | 3,557 | 4,058 | ||
| Non-controlling interests | -1,254 | -1,226 | ||
| Total stockholders equity | 2,303 | 2,832 | ||
| Total liabilities and stockholders equity | 3,725 | 4,161 | ||
AVENUE THERAPEUTICS, INC. (ATXI)
AVENUE THERAPEUTICS, INC. (ATXI)